George Cannon

George Cannon, MD

Languages spoken: English

Academic Information

Departments Adjunct - Radiation Oncology

Academic Office Information

gmc8@utah.edu

Education History

Residency University of Wisconsin Hospital and Clinics
 Resident
Residency Mallinckrodt Institute of Radiology, BJC, Washington University
 Resident
Residency LDS Hospital/Intermountain Health Care
 Resident
Professional Medical University of Utah School of Medicine
 MD
Undergraduate Brigham Young University
 BS

Selected Publications

Journal Article

  1. Bagshaw HP, Sause WT, Gawlick U, Kim HT, Whisenant J, Cannon GM (2016). Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus. Am J Clin Oncol. (Read full article)
  2. Kruser TJ, McCabe BP, Mehta MP, Khuntia D, Campbell TC, Geye HM, Cannon GM (2014). Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma. Am J Clin Oncol, 37(1), 70-6. (Read full article)
  3. Cannon DM, Mehta MP, Adkison JB, Khuntia D, Traynor AM, Tome WA, Chappell RJ, Tolakanahalli R, Mohindra P, Bentzen SM, Cannon GM (2013). Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. J Clin Oncol, 31(34), 4343-8. (Read full article)
  4. Cannon DM, McHaffie DR, Patel RR, Adkison JB, Das RK, Anderson BD, Geye HM, Bentzen SM, Cannon GM (2013). Locoregional recurrence following accelerated partial breast irradiation for early-stage invasive breast cancer: significance of estrogen receptor status and other pathological variables. Ann Surg Oncol, 20(11), 3446-52. (Read full article)
  5. McHaffie DR, Patel RR, Adkison JB, Das RK, Geye HM, Cannon GM (2011). Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Int J Radiat Oncol Biol Phys, 81(1), 46-51. (Read full article)
  6. Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, Mehta MP, Bentzen SM (2011). Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer. Acta Oncol, 50(6), 772-6. (Read full article)
  7. Schubert LK, Gondi V, Sengbusch E, Westerly DC, Soisson ET, Paliwal BR, Mackie TR, Mehta MP, Patel RR, Tome WA, Cannon GM (2011). Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol, 100(2), 241-6. (Read full article)
  8. Vogelius IS, Westerly DC, Cannon GM, Mackie TR, Mehta MP, Sugie C, Bentzen SM (2011). Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping. Int J Radiat Oncol Biol Phys, 80(3), 893-9. (Read full article)
  9. Vogelius IS, Westerly DC, Cannon GM, Bentzen SM (2010). Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol, 49(7), 1052-7. (Read full article)
  10. Cannon GM, Geye H, Terakedis BE, Kushner DM, Connor JP, Hartenbach EM, Bradley KA (2009). Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma. Gynecol Oncol, 113(2), 176-80. (Read full article)
  11. Adkison JB, Khuntia D, Bentzen SM, Cannon GM, Tome WA, Jaradat H, Walker W, Traynor AM, Weigel T, Mehta MP (2008). Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat, 7(6), 441-7. (Read full article)
  12. Ghia A, Tome WA, Thomas S, Cannon GM, Khuntia D, Kuo JS, Mehta MP (2007 July 15). Distribution of Brain Metastases in Relation to the Hippocampus: Implications for Neurocognitive Functional Preservation. Int J Radiat Oncol Biol Phys, 68(4), 971-7.

Case Report

  1. Cannon GM, Tome WA, Robins HI, Howard SP (2007). Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme. J Neurooncol, 83(3), 307-11. (Read full article)